China Top Transseptal Access System Manufacturers & Exporter

Leading the Future of Cardiovascular Intervention with Precision-Engineered Access Solutions

🌐 Global Market & Industrial Status

The global Transseptal Access System market is experiencing a paradigm shift driven by the rising incidence of Atrial Fibrillation (AFib) and the expansion of Left Atrial Appendage Closure (LAAC) procedures.

In today's interventional cardiology landscape, transseptal access serves as the "gateway" to the left heart. As structural heart interventions grow more complex, the demand for integrated systems that combine puncture needles, dilators, and steerable guiding sheaths has surged. This industrial evolution is moving away from generic tools toward specialized, procedure-specific systems designed for mitral valve repair, ablation, and paravalvular leak closure.

Current industrial trends emphasize miniaturization and radiopacity. Hospitals in North America and Europe are increasingly seeking "One-Shot" solutions—systems that provide stable access with minimal trauma, reducing procedural time and improving patient safety outcomes. As a result, the market is no longer just about the device; it's about the procedural efficiency it enables.

Advanced Vascular Lab

🚀 Cutting-Edge Industry Trends

Steerable Technology

Modern systems now incorporate multi-directional steering mechanisms, allowing surgeons to navigate difficult anatomical variations in the right atrium with unprecedented precision.

🔍

Imaging Integration

The integration of Echo-compatible materials ensures that the transseptal needle and sheath are clearly visible under ICE (Intracardiac Echocardiography), reducing fluoroscopy time.

🛡

Atraumatic Designs

Next-generation dilators utilize hydrophilic coatings and tapered tips to ensure a smooth crossing of the septum, significantly lowering the risk of unintended perforations.

🏭 About Hangzhou SJ Medical Co., Ltd.

SJ Medical Manufacturing Facility

Hangzhou SJ Medical Co., Ltd. was established in 2015 and is dedicated to the research, development, manufacturing, and commercialization of vascular interventional medical devices. The company focuses on both cardiovascular and peripheral intervention fields, striving to provide safe, reliable, and innovative solutions for healthcare providers worldwide.

Through continuous innovation and strong R&D capabilities, SJ Medical has obtained multiple patents and international certifications, including CE, ISO 13485, and CFDA approval. We operate a modern 5,000 square meter facility with high-standard cleanrooms, ensuring every Transseptal Access System meets stringent global medical standards.

2015Established
5,000+Sqm Factory
CE/ISOCertified Quality
20+Global Partners

📦 Global Procurement & Our Advantage

Why international hospitals and distributors are turning to China's leading manufacturers for Transseptal Access solutions.

💵

Cost-Efficiency

We provide high-performance devices at a competitive price point, helping healthcare systems manage rising costs without compromising on patient clinical outcomes.

🚚

Supply Chain Stability

Our integrated manufacturing ensures consistent supply and rapid turnaround times, a critical factor for global procurement managers facing logistics challenges.

👨‍🔬

Customized OEM/ODM

Leveraging our decades of engineering experience, we offer tailored solutions to meet specific regional clinical requirements and localized application scenarios.

As a leading China Transseptal Access System Manufacturer, SJ Medical bridges the gap between high-tech innovation and accessible healthcare. Our products are widely applied in minimally invasive procedures involving both coronary and peripheral vascular systems. They play an important role in the diagnosis and treatment of vascular diseases, helping to improve procedural efficiency while enhancing patient safety and recovery.

🏥 Clinical Application Scenarios

Our systems are engineered for diverse clinical environments, from state-of-the-art hybrid ORs in Europe to high-volume catheterization labs in Southeast Asia. Key applications include:

  • AFib Ablation: Facilitating precise left atrial entry for cryoballoon or radiofrequency ablation.
  • LAA Closure: Providing the stable platform required for the delivery of occlusion devices.
  • Mitral Valve Interventions: Enabling transseptal access for MitraClip or similar repair technologies.
  • Pediatric Cardiology: Specialized small-diameter sheaths for congenital heart defect repairs.

Global Distribution Reach

Currently distributed in: Italy, Finland, Spain, France, Netherlands, India, Indonesia, Turkey, Egypt, and beyond.

🔬 Advanced Production & Quality Control

The company is equipped with advanced production and inspection systems, including precision balloon forming equipment, laser welding and marking technologies, and comprehensive laboratory testing facilities. These capabilities ensure high levels of manufacturing accuracy, product consistency, and full-process quality control.

Our million-class clean workshop and localized hundred-class areas for critical processes guarantee that every catheter and sheath is free from contaminants, ensuring bio-compatibility and patient safety during every invasive procedure.

Laser Welding
Balloon Forming
Lab Testing
GMP Cleanroom